Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01492465 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Dose Trial in Patients With Type 2 Diabetes
A Phase 1 study, sponsored by Amgen.
- Terminated
- Registry status
- Phase 1
- Development phase
- 47
- Enrollment target
NCT01492465: Clinical Trial Phase 1 study, sponsored by Amgen.
NCT01492465 is a Phase 1 study that was terminated before completion, run by Amgen. The registered enrollment target is 47 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01492465, a Phase 1 study, was terminated before completion, sponsored by Amgen.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether AMG 876 is safe and well tolerated in subjects with type 2 diabetes.
Primary Outcome
Physical examinations, vitals, clinical laboratories, and ECGs
Interventions
- DRUG AMG 876
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
Why NCT01492465 stopped before completion
NCT01492465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 1 intervention - of which AMG 876 is the first listed.
NCT01492465 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01492465 about?
NCT01492465 is a clinical study titled "Single Ascending Dose Trial in Patients With Type 2 Diabetes". The purpose of this study is to determine whether AMG 876 is safe and well tolerated in subjects with type 2 diabetes.
What is the current status of trial NCT01492465?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2011-11. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01492465?
The interventions under investigation include: AMG 876 (DRUG).
Who is sponsoring clinical trial NCT01492465?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01492465's enrollment target sits among peer trials
47 1053rd of 2000 higher than 943 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia